Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Statins can decrease hepatocellular carcinoma (HCC) occurrence, but the magnitude and the predictors of these effects remain unclear. This meta-analysis provides a pooled estimate of the impact of statin use on HCC occurrence. Pooled effects were calculated using a random-effects model by means of t...
Main Authors: | Antonio Facciorusso, Mohamed A Abd El Aziz, Siddharth Singh, Sara Pusceddu, Massimo Milione, Luca Giacomelli, Rodolfo Sacco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/4/874 |
Similar Items
-
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
by: Antonio Facciorusso, et al.
Published: (2020-12-01) -
Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
by: Mohamed A. Abd El Aziz, et al.
Published: (2020-10-01) -
Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
by: Antonio Facciorusso, et al.
Published: (2020-04-01) -
Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
by: Antonio Facciorusso, et al.
Published: (2020-10-01) -
Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
by: Maria Tampaki, et al.
Published: (2023-02-01)